Hepatoma Research

Articles

Most Recent | Most Viewed | Most Downloaded

Functions and potential clinical applications of circular RNAs in hepatocellular carcinoma

Abstract:
Hepatocellular carcinoma (HCC), which accounts for 75%-80% of primary liver cancers, is recognized worldwide as a highly lethal cancer. Adjunctive diagnostic... MORE
Open Access Review DOI: 10.20517/2394-5079.2024.123 2 Jul 2025
Views: Downloads:
Download PDF

Importance of critical tumor features in multidisciplinary multi-parametric assessment of HCC

Abstract:
Hepatocellular carcinoma (HCC) is a complex malignancy that necessitates a multidisciplinary approach to optimize diagnosis, treatment, and management. The... MORE
Open Access Review DOI: 10.20517/2394-5079.2024.146 4 Jun 2025
Views: Downloads:
Download PDF

Screening for lipid metabolism-related genes and identifying the therapeutic potential of ACACA for ER stress-related progression in hepatocellular carcinoma

Abstract:
Aim: The reprogramming of lipid metabolism can markedly enhance the nutritional adaptability of tumor cells to the glucose-deficient and hypoxic tumor... MORE
Open Access Original Article DOI: 10.20517/2394-5079.2024.135 28 May 2025
Views: Downloads:
Download PDF

Predicting microvascular invasion plus cytokeratin 19 expression positivity in hepatocellular carcinoma based on EOB-MRI using multitask deep learning

Abstract:
Aim: To construct and validate a multitask deep learning (DL) model based on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)... MORE
Open Access Original Article DOI: 10.20517/2394-5079.2024.143 26 Apr 2025
Views: Downloads:
Download PDF

HCC in MASLD: radiological appearance, diagnosis and treatment

Abstract:
Metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), are... MORE
Open Access Review DOI: 10.20517/2394-5079.2024.117 22 Apr 2025
Views: Downloads:
Download PDF

Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease

Abstract:
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. This term does not describe the pathogenetic mechanisms and... MORE
Open Access Review DOI: 10.20517/2394-5079.2023.134 28 Mar 2024
Views: Downloads:
Download PDF

Issue on combined locoregional and systemic treatment for hepatocellular carcinoma

Abstract:
Treatment for hepatocellular carcinoma (HCC) has been challenging as most patients present with late, advanced disease, where curative options are limited. For... MORE
Open Access Review DOI: 10.20517/2394-5079.2022.37 15 Mar 2023
Views: Downloads:
Download PDF

Barriers to surveillance for hepatocellular cancer among patients with chronic liver disease -providers' perspectives

Abstract:
Aims: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. While patients who are known to be at high risk for HCC should be... MORE
Open Access Original Article DOI: 10.20517/2394-5079.2023.75 29 Oct 2023
Views: Downloads:
Download PDF
1 / 23
The Selection Committee of Hepatoma Research has identified five papers as exemplary contributions
Advancing Liver Cancer Research Together – ILCA 2025
Distinguished Member of the Korean Academy of Science and Technology
Hepatoma Research Achieves Significant Increase with a 2024 CiteScore of 3.5!
This prestigious ranking identifies the top 2% of scientists globally from over 7 million scientists, spanning 22 fields and 174 sub-disciplines.
The Selection Committee of Hepatoma Research has identified five papers as exemplary contributions
Advancing Liver Cancer Research Together – ILCA 2025
1 / 23
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/